DSIP (Delta Sleep-Inducing Peptide)

DSIP (Delta Sleep-Inducing Peptide) is a 9-amino acid neuropeptide originally isolated from the cerebral venous blood of rabbits during electrically induced sleep states. The compound crosses the blood-brain barrier and has been shown to modulate stress-related hormones including cortisol and ACTH through hypothalamic-pituitary-adrenal (HPA) axis interactions. In preclinical sleep architecture studies, DSIP promoted delta wave (slow-wave) sleep without suppressing REM sleep stages, distinguishing it mechanistically from most conventional sedative compounds. Its unique pharmacological profile has made it a subject of interest in chronobiology, stress physiology, and neuroendocrine research.

Key Research Findings:

• Rodent studies showed promotion of delta wave sleep with preserved REM architecture, unlike GABAergic or antihistaminergic sedative mechanisms
• Preclinical models demonstrated modulation of stress-induced cortisol and ACTH elevations through HPA axis interactions
• BBB penetration studies confirmed central nervous system bioavailability following peripheral administration in animal models
• Chronobiology research in rodents indicated circadian rhythm normalization effects under disrupted light-dark cycle conditions

For laboratory and research use only.